Stockreport

TapImmune's (TPIV) Proposed Merger with Marker Therapeutics (Transcript) [Seeking Alpha]

TAPIMMUNE INC COMMON  (TPIV) 
NASDAQ:AMEX Investor Relations: tapimmune.com/investors
PDF TapImmune Inc. (NASDAQ: TPIV ) Investor Breakfast to Discuss Proposed Merger with Marker Therapeutics May 15, 2018 9:30 AM ET Executives Peter Hoang - Preside [Read more]